-
Something wrong with this record ?
Parkin (PARK 2) mutations are rare in Czech patients with early-onset Parkinson's disease
O. Fiala, D. Zahorakova, L. Pospisilova, J. Kucerova, M. Matejckova, P. Martasek, J. Roth, E. Ruzicka,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NT11331
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Directory of Open Access Journals
from 2006
Free Medical Journals
from 2006
Public Library of Science (PLoS)
from 2006
PubMed Central
from 2006
Europe PubMed Central
from 2006
ProQuest Central
from 2006-12-01
Open Access Digital Library
from 2006-01-01
Open Access Digital Library
from 2006-10-01
Open Access Digital Library
from 2006-01-01
Medline Complete (EBSCOhost)
from 2008-01-01
Nursing & Allied Health Database (ProQuest)
from 2006-12-01
Health & Medicine (ProQuest)
from 2006-12-01
Public Health Database (ProQuest)
from 2006-12-01
ROAD: Directory of Open Access Scholarly Resources
from 2006
- MeSH
- Genotype MeSH
- Humans MeSH
- Mutation * MeSH
- Parkinson Disease genetics MeSH
- Sequence Deletion MeSH
- Ubiquitin-Protein Ligases genetics MeSH
- Age Factors MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
OBJECTIVE: The aim of the study is to determine the frequency of parkin allelic variants in Czech early-onset Parkinson's disease patients and healthy controls. METHODS: A total of 70 early-onset Parkinson's disease patients (age at onset ≤40 years) and 75 controls were screened for the sequence variants and exon rearrangements in the parkin gene. RESULTS: Parkin mutations were identified in five patients (7.1%): the p.R334C point mutation was present in one patient, four patients had exon deletions. The detected mutations were observed in the heterozygous state except one homozygous deletion of the exon 4. No mutations were obtained in control subjects. A novel sequence variant p.V380I (c.1138G>A) was identified in one control. Non-pathogenic polymorphisms p.S167N and p.D394N were seen in similar percentage in patients and controls, polymorphism p.V380L was almost twice as frequent in controls as in patients. CONCLUSIONS: Our study contributes to the growing body of evidence on the low frequency of the parkin mutations in the early-onset Parkinson's disease suggesting the potential role of other genes in the pathogenesis of the disease.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15023020
- 003
- CZ-PrNML
- 005
- 20181016143704.0
- 007
- ta
- 008
- 150709s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.pone.0107585 $2 doi
- 035 __
- $a (PubMed)25238391
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Fiala, Ondřej, $u Department of Neurology and Centre of Clinical Neuroscience, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic; Institute of Neuropsychiatric Care (INEP), Prague, Czech Republic. $d 1980- $7 xx0064587
- 245 10
- $a Parkin (PARK 2) mutations are rare in Czech patients with early-onset Parkinson's disease / $c O. Fiala, D. Zahorakova, L. Pospisilova, J. Kucerova, M. Matejckova, P. Martasek, J. Roth, E. Ruzicka,
- 520 9_
- $a OBJECTIVE: The aim of the study is to determine the frequency of parkin allelic variants in Czech early-onset Parkinson's disease patients and healthy controls. METHODS: A total of 70 early-onset Parkinson's disease patients (age at onset ≤40 years) and 75 controls were screened for the sequence variants and exon rearrangements in the parkin gene. RESULTS: Parkin mutations were identified in five patients (7.1%): the p.R334C point mutation was present in one patient, four patients had exon deletions. The detected mutations were observed in the heterozygous state except one homozygous deletion of the exon 4. No mutations were obtained in control subjects. A novel sequence variant p.V380I (c.1138G>A) was identified in one control. Non-pathogenic polymorphisms p.S167N and p.D394N were seen in similar percentage in patients and controls, polymorphism p.V380L was almost twice as frequent in controls as in patients. CONCLUSIONS: Our study contributes to the growing body of evidence on the low frequency of the parkin mutations in the early-onset Parkinson's disease suggesting the potential role of other genes in the pathogenesis of the disease.
- 650 _2
- $a věkové faktory $7 D000367
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a Parkinsonova nemoc $x genetika $7 D010300
- 650 _2
- $a sekvenční delece $7 D017384
- 650 _2
- $a ubikvitinligasy $x genetika $7 D044767
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Záhoráková, Daniela $u Department of Pediatrics and Adolescent Medicine, 1st Faculty of Medicine, and General University Hospital, Charles University, Prague, Czech Republic. $7 xx0074483
- 700 1_
- $a Pospíšilová, Lenka $u Department of Pediatrics and Adolescent Medicine, 1st Faculty of Medicine, and General University Hospital, Charles University, Prague, Czech Republic. $7 xx0142906
- 700 1_
- $a Kucerova, Jana $u Department of Pediatrics and Adolescent Medicine, 1st Faculty of Medicine, and General University Hospital, Charles University, Prague, Czech Republic.
- 700 1_
- $a Matějčková, Milada $u Department of Pathology and Molecular Medicine, Thomayer's University Hospital, Prague, Czech Republic. $7 xx0150513
- 700 1_
- $a Martásek, Pavel, $u Department of Pediatrics and Adolescent Medicine, 1st Faculty of Medicine, and General University Hospital, Charles University, Prague, Czech Republic. $d 1952- $7 xx0077949
- 700 1_
- $a Roth, Jan, $u Department of Neurology and Centre of Clinical Neuroscience, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic. $d 1961- $7 jo20000074063
- 700 1_
- $a Růžička, Evžen, $u Department of Neurology and Centre of Clinical Neuroscience, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic. $d 1957- $7 jo20000074065
- 773 0_
- $w MED00180950 $t PloS one $x 1932-6203 $g Roč. 9, č. 9 (2014), s. e107585
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25238391 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150709 $b ABA008
- 991 __
- $a 20181016144202 $b ABA008
- 999 __
- $a ok $b bmc $g 1083359 $s 906013
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 9 $c 9 $d e107585 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
- GRA __
- $a NT11331 $p MZ0
- LZP __
- $a Pubmed-20150709